TY  - GEN
AU  - Papp,K A
AU  - Kaufmann,R
AU  - Thaçi,D
AU  - Hu,C
AU  - Sutherland,D
AU  - Rohane,P
TI  - Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study
SN  - 1468-3083
PY  - 2014///0923
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - adverse effects
KW  - Double-Blind Method
KW  - Humans
KW  - Placebos
KW  - Psoriasis
KW  - drug therapy
KW  - Severity of Illness Index
KW  - Thalidomide
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1468-3083.2012.04716.x
ER  -